Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
European Child & Adolescent Psychiatry|September 15, 2016
Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
Journal of Child and Adolescent Psychopharmacology|June 16, 2017
Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
Pharmacoepidemiology and Drug Safety|August 26, 2017
Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
Pharmacoepidemiology and Drug Safety|November 22, 2016
Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
European Journal of Clinical Pharmacology|May 27, 2014
Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospitalKathrin Jobski, Dirk Enders, Ute Amann, et al.
Journal of Physical Activity & Health|September 28, 2011
Association of physical activity and atrial fibrillationFalk Müller-Riemenschneider, Frank Andersohn, Sabine Ernst, et al.
Journal of Medical Economics|February 19, 2015
Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims dataBernd Brüggenjürgen, Frank Andersohn, Nadja Ezzat, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 6, 2020
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in GermanyMarion Ludwig, Josephine Jacob, Frederike Basedow, et al.
Pageof 14